Start of a new bull market for 2023 or a bear market rally?
Marc Kennis, November 14, 2022
Bear market rally, or start of a bull market?
Stuart Roberts from Pitt Street Research says its the start of a bull market. He cites the central banks tightening interest rates, a response from pricing and the global economy returning to normal. Stuart still backs Medibank, who didn’t pay the hackers ransom, and he thinks this will result in an interesting investor response and people should watch it carefully.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Turning to the Star Entertainment Group, Stuart says the worst that can happen is the regulator takes away their licenses, but this didn’t happen in NSW. He says the casinos are imporant tourist attractions and the markets aren’t currently pricing in any of the upsides to Star as the post-Covid economy returns to normal. Star also has a new CEO with elaborate plans to clean house. And Medibank will probably also do well in a new bull market.
Watch the entire Ausbiz interview here!
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
These 2 ASX Healthcare Stocks Are Quietly Cashing In on the AI Revolution
ASX Healthcare Stocks Benefiting From AI Artificial intelligence is reshaping healthcare faster than most investors realise. Hospital imaging systems, pathology…
Which ASX Uranium Stocks Benefit Most From the Iran War and the Hormuz Oil Crisis?
ASX Uranium Stocks to Watch This Week Brent crude is sitting just above US$111 a barrel as of this morning,…
Telix pharmaceuticals (ASX: TLX) A$230m Quarter Puts Guidance Back In Play
Is Telix in Turnaround Mode or Dead-Cat Bounce? The question investors are now asking about Telix pharmaceuticals is whether the…